Haven't used Matricelf yet?
Ask Trustburn

Questions about Matricelf

Based on 11 reviews, listing data and website checks · updated 3 days ago

What is Matricelf?

Matricelf is a biotechnology company specializing in autologous 3D tissue engineering for regenerative medicine. Founded in 2019 by Alon Sinai, PhD, and Professor Tal Dvir at Tel Aviv University, the company develops curative, patient-specific therapies aimed at restoring function in patients with severe neurological injuries. Their proprietary technology creates fully autologous engineered tissues using patient-derived extracellular matrix and iPSCs, enabling personalized treatments with reduced rejection risk.

Who is Matricelf's therapy intended for?

The company targets patients suffering from spinal cord injury (SCI), stroke, traumatic brain injury (TBI), myocardial infarction, and Parkinson's disease. By engineering functional neural implants from a patient's own cells and tissue, Matricelf offers a one-time treatment designed to bridge damaged spinal tissue and restore lost movement, function, and independence.

How does the patient-specific tissue engineering process work?

The treatment process begins with collecting the patient's blood to produce induced Pluripotent Stem Cells (iPSCs). A small sample of the patient's omentum undergoes a proprietary decellularization process to form a thermo-responsive hydrogel, where the stem cells are differentiated to generate the desired tissue before being implanted.

What makes Matricelf's regenerative platform unique?

Matricelf's proprietary technology differentiates iPSCs within a patient-specific extracellular matrix (ECM) to engineer functional neural implants. This approach addresses multiple indications including stroke, TBI, myocardial infarction, and Parkinson's disease, aiming to provide a curative solution for conditions with no effective cure.

Where is Matricelf based and what industry does it serve?

The company is located at Golda Meir 3 Ness Ziona, Israel, and operates primarily within the biotechnology sector. Their headquarters in Israel positions them to serve the global market for advanced regenerative medicine solutions targeting severe neurological injuries.

How recent and how many reviews does Matricelf have?

As of 2026, Matricelf has a Trustburn rating of 3.8 out of 5 from 11 reviews. The reviews are recent, with the most recent posted on November 24, 2023, and the oldest on December 25, 2022, covering a span of over a year.

What do reviewers praise about Matricelf?

Reviewers frequently praise Matricelf for its user-friendly website, high-quality products, reasonable prices, and fast shipping. Many customers highlight excellent customer service, helpful and responsive support teams, and products that met or exceeded their expectations.

What does recent news say about Matricelf's clinical progress?

News articles from late 2026 report that Matricelf achieved statistically significant motor function improvement in a preclinical efficacy study of chronic spinal cord injury, with 63% of treated animals showing at least five points of improvement versus 11.5% of controls.

What regulatory approvals has Matricelf recently obtained?

In September 2026, Matricelf secured preliminary approval from Israel’s Ministry of Health to conduct compassionate use trials for engineered spinal cord tissue implants, marking a major regulatory milestone for their first-in-human studies.

What are Matricelf's upcoming business milestones?

The company is preparing for a planned Nasdaq dual listing and is seeking an investment banking partner for a potential follow-on offering to support its transition into first-in-human studies ahead of the NIBA's 153rd Investment Conference.

Who are the key leaders behind Matricelf?

Matricelf's management team includes CEO Gil Hakim, Co-Founder and Deputy CEO Alon Sinai, PhD, CFO Sigal Russo, and Co-Founder and CSO Prof. Tal Dvir, PhD, who is a pioneer in regenerative medicine trained at MIT under Prof. Robert Langer.

Who comprises Matricelf's scientific and clinical advisory boards?

The company's scientific advisory board includes experts such as Dr. Ruchi Sharma, PhD, Eckhard von Keutz, PhD, and Dr. Adam Wollowick, MD, while its clinical advisory board features Prof. Nachshon Knoller, M.D., and Prof. Allan D. Levi, M.D., PhD.

How can potential partners or patients contact Matricelf?

To get in touch, visitors can use the contact form on the website or reach out via email at [email protected]. The company also maintains social profiles on LinkedIn and Facebook for further engagement.

What specific medical conditions does Matricelf aim to treat?

Matricelf's website states that their novel regenerative medicine platform enables treatment of a range of medical conditions, positioning them as a solution provider for urgent unmet needs in neurology and beyond.

What is the official website of Matricelf?

The official website of Matricelf is matricelf.com.

Based on reviews, listing data and the company's website. Verify anything important with the company directly.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="matricelf" data-lang="en"></div>
More widgets

About Matricelf

Categories
Biotechnology